Clinical Trial Update: Universal CNK-UT Therapy for Refractory aGVHD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for Universal CNK-UT Therapy targeting refractory acute graft-versus-host disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Universal CNK-UT Therapy

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Graft-versus-Host Disease | Phase 1 | Status: RECRUITING